GSK files shingles vaccine in EU
Shingrix has billion dollar sales potential, according to analysts.
shingles
GSK files shingles vaccine in US
Shingrix has blockbuster potential, according to analysts.
Shingrix has billion dollar sales potential, according to analysts.
Shingrix has blockbuster potential, according to analysts.